α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease

Output Details

Preprint December 15, 2023

Published October 8, 2024

Abstract Background Pathological accumulation of aggregated α-synuclein (aSYN) is a common feature of Parkinson’s disease (PD). However, the mechanisms by which intracellular aSYN pathology contributes to dysfunction and degeneration of neurons in the brain are still unclear. A potentially relevant target of aSYN is the mitochondrion. To test this hypothesis, genetic and physiological methods were used to monitor mitochondrial function in substantia nigra pars compacta (SNc) dopaminergic and pedunculopontine nucleus (PPN) cholinergic neurons after stereotaxic injection of aSYN pre-formed fibrils (PFFs) into the mouse brain. Methods aSYN PPFs were stereotaxically injected into the SNc or PPN of mice. Twelve weeks later, mice were studied using a combination of approaches, including immunocytochemical analysis, cell- type specific transcriptomic profiling, electron microscopy, electrophysiology and two-photon-laser- scanning microscopy of genetically encoded sensors for bioenergetic and redox status. Results In addition to inducing a significant neuronal loss, SNc injection of PFFs induced the formation of intracellular, phosphorylated aSYN aggregates selectively in dopaminergic neurons. In these neurons, PFF-exposure decreased mitochondrial gene expression, reduced the number of mitochondria, increased oxidant stress, and profoundly disrupted mitochondrial adenosine triphosphate production. Consistent with an aSYN-induced bioenergetic deficit, the autonomous spiking of dopaminergic neurons slowed or stopped. PFFs also up-regulated lysosomal gene expression and increased lysosomal abundance, leading to the formation of Lewy-like inclusions. Similar changes were observed in PPN cholinergic neurons following aSYN PFF exposure. Conclusions Taken together, our findings suggest that disruption of mitochondrial function, and the subsequent bioenergetic deficit, is a proximal step in the cascade of events induced by aSYN pathology leading to dysfunction and degeneration of neurons at-risk in PD.
Tags
  • Original Research

Meet the Authors

  • User avatar fallback logo

    Fanni F. Geibl

  • User avatar fallback logo

    Martin T. Henrich

  • User avatar fallback logo

    Zhong Xie

  • User avatar fallback logo

    Enrico Zampese, PhD

    Key Personnel: Team Surmeier

    Northwestern University

  • User avatar fallback logo

    Tatiana Tkatch

  • User avatar fallback logo

    David L. Wokosin

  • User avatar fallback logo

    Elena Nasiri

  • User avatar fallback logo

    Constantin A. Grotmann

  • User avatar fallback logo

    Valina L. Dawson

  • Ted Dawson, MD, PhD

    Co-PI (Core Leadership): Team Kaplitt

    Johns Hopkins Medicine

  • User avatar fallback logo

    Navdeep S. Chandel

  • User avatar fallback logo

    Wolfgang Oertel

  • James Surmeier, PhD

    Lead PI (Core Leadership): Team Surmeier

    Northwestern University